138 related articles for article (PubMed ID: 16284552)
1. Human recombinant factor VII for emergency reversal of coagulopathy in neurosurgical patients: a retrospective comparative study.
Roitberg B; Emechebe-Kennedy O; Amin-Hanjani S; Mucksavage J; Tesoro E
Neurosurgery; 2005 Nov; 57(5):832-6; discussion 832-6. PubMed ID: 16284552
[TBL] [Abstract][Full Text] [Related]
2. Rapid Warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate.
Woo CH; Patel N; Conell C; Rao VA; Faigeles BS; Patel MC; Pombra J; Akins PT; Axelrod YK; Ge IY; Sheridan WF; Flint AC
World Neurosurg; 2014 Jan; 81(1):110-5. PubMed ID: 23220122
[TBL] [Abstract][Full Text] [Related]
3. Use of recombinant factor VIIa in patients with warfarin-associated intracranial hemorrhage.
Brody DL; Aiyagari V; Shackleford AM; Diringer MN
Neurocrit Care; 2005; 2(3):263-7. PubMed ID: 16159073
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Fresh-Frozen Plasma, Four-Factor Prothrombin Complex Concentrates, and Recombinant Factor VIIa to Facilitate Procedures in Critically Ill Patients with Coagulopathy from Liver Disease: A Retrospective Cohort Study.
Kwon JO; MacLaren R
Pharmacotherapy; 2016 Oct; 36(10):1047-1054. PubMed ID: 27547916
[TBL] [Abstract][Full Text] [Related]
5. Prothrombin complex concentrates to reverse warfarin-induced coagulopathy in patients with intracranial bleeding.
Cabral KP; Fraser GL; Duprey J; Gibbons BA; Hayes T; Florman JE; Seder DB
Clin Neurol Neurosurg; 2013 Jun; 115(6):770-4. PubMed ID: 22835715
[TBL] [Abstract][Full Text] [Related]
6. Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy.
Shami VM; Caldwell SH; Hespenheide EE; Arseneau KO; Bickston SJ; Macik BG
Liver Transpl; 2003 Feb; 9(2):138-43. PubMed ID: 12548507
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of Factor IX complex concentrate in reversing warfarin associated coagulopathy for intracerebral hemorrhage.
Siddiq F; Jalil A; McDaniel C; Brock DG; Pineda CC; Bell RD; Lee K
Neurocrit Care; 2008; 8(1):36-41. PubMed ID: 17898941
[TBL] [Abstract][Full Text] [Related]
8. The role of four-factor prothrombin complex concentrate in coagulopathy of trauma: A propensity matched analysis.
Jehan F; Aziz H; OʼKeeffe T; Khan M; Zakaria ER; Hamidi M; Zeeshan M; Kulvatunyou N; Joseph B
J Trauma Acute Care Surg; 2018 Jul; 85(1):18-24. PubMed ID: 29664892
[TBL] [Abstract][Full Text] [Related]
9. Prothrombin complex concentrate accelerates international normalized ratio reversal and diminishes the extension of intracranial hemorrhage in geriatric trauma patients.
Edavettal M; Rogers A; Rogers F; Horst M; Leng W
Am Surg; 2014 Apr; 80(4):372-6. PubMed ID: 24887668
[TBL] [Abstract][Full Text] [Related]
10. Use of prothrombin complex concentrate as an adjunct to fresh frozen plasma shortens time to craniotomy in traumatic brain injury patients.
Joseph B; Pandit V; Khalil M; Kulvatunyou N; Aziz H; Tang A; OʼKeeffe T; Hays D; Gries L; Lemole M; Friese RS; Rhee P
Neurosurgery; 2015 May; 76(5):601-7; discussion 607. PubMed ID: 25886249
[TBL] [Abstract][Full Text] [Related]
11. Reversal of coagulopathy in critically ill patients with traumatic brain injury: recombinant factor VIIa is more cost-effective than plasma.
Stein DM; Dutton RP; Kramer ME; Scalea TM
J Trauma; 2009 Jan; 66(1):63-72; discussion 73-5. PubMed ID: 19131807
[TBL] [Abstract][Full Text] [Related]
12. Recombinant factor VIIa to correct coagulopathy in patients with traumatic brain injury presenting to outlying facilities before transfer to the regional trauma center.
Brown CV; Sowery L; Curry E; Valadka AB; Glover CS; Grabarkewitz K; Green T; Hail S; Admire J
Am Surg; 2012 Jan; 78(1):57-60. PubMed ID: 22273315
[TBL] [Abstract][Full Text] [Related]
13. Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy.
Makris M; Greaves M; Phillips WS; Kitchen S; Rosendaal FR; Preston EF
Thromb Haemost; 1997 Mar; 77(3):477-80. PubMed ID: 9065997
[TBL] [Abstract][Full Text] [Related]
14. The use of activated recombinant factor VII in a patient with fulminant hepatic failure requiring placement of an intracranial pressure monitor.
Meadows HB; Krisl JC; Greenberg CS; Mazur JE
Ann Pharmacother; 2011 Nov; 45(11):e60. PubMed ID: 22028416
[TBL] [Abstract][Full Text] [Related]
15. Timing of fresh frozen plasma administration and rapid correction of coagulopathy in warfarin-related intracerebral hemorrhage.
Goldstein JN; Thomas SH; Frontiero V; Joseph A; Engel C; Snider R; Smith EE; Greenberg SM; Rosand J
Stroke; 2006 Jan; 37(1):151-5. PubMed ID: 16306465
[TBL] [Abstract][Full Text] [Related]
16. A Retrospective Propensity Score-Matched Early Thromboembolic Event Analysis of Prothrombin Complex Concentrate vs Fresh Frozen Plasma for Warfarin Reversal Prior to Emergency Neurosurgical Procedures.
Agarwal P; Abdullah KG; Ramayya AG; Nayak NR; Lucas TH
Neurosurgery; 2018 Jun; 82(6):877-886. PubMed ID: 29106685
[TBL] [Abstract][Full Text] [Related]
17. Fresh frozen plasma should be given earlier to patients requiring massive transfusion.
Gonzalez EA; Moore FA; Holcomb JB; Miller CC; Kozar RA; Todd SR; Cocanour CS; Balldin BC; McKinley BA
J Trauma; 2007 Jan; 62(1):112-9. PubMed ID: 17215741
[TBL] [Abstract][Full Text] [Related]
18. Utilization of recombinant activated factor VII for intracranial hematoma evacuation in coagulopathic nonhemophilic neurosurgical patients with normal international normalized ratios.
McClelland S; Won EK; Lam CH
Neurocrit Care; 2007; 7(2):136-9. PubMed ID: 17846720
[TBL] [Abstract][Full Text] [Related]
19. Safety and Effectiveness of Factor VIII Inhibitor Bypassing Activity (FEIBA) and Fresh Frozen Plasma in Oral Anticoagulant-Associated Intracranial Hemorrhage: A Retrospective Analysis.
Yin EB; Tan B; Nguyen T; Salazar M; Putney K; Gupta P; Suarez JI; Bershad EM
Neurocrit Care; 2017 Aug; 27(1):51-59. PubMed ID: 28243997
[TBL] [Abstract][Full Text] [Related]
20. Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trial.
Steiner T; Poli S; Griebe M; Hüsing J; Hajda J; Freiberger A; Bendszus M; Bösel J; Christensen H; Dohmen C; Hennerici M; Kollmer J; Stetefeld H; Wartenberg KE; Weimar C; Hacke W; Veltkamp R
Lancet Neurol; 2016 May; 15(6):566-73. PubMed ID: 27302126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
